MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, XNCR made $20,999K in revenue. -$6,027K in net income. Net profit margin of -28.70%.

Income Overview

Revenue
$20,999K
Net Income
-$6,027K
Net Profit Margin
-28.70%
EPS
-$0.08
Unit: Thousand (K) dollars
Revenue Breakdown
    • Alexion Pharmaceuticals Inc
    • Incyte Corporation
    • Vir Biotechnology Inc.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-12-31
Collaborations, milestones, and royalties
20,999 43,608 32,732 52,793
Research and development
54,367 61,665 58,578 51,056
General and administrative
14,151 15,115 17,337 14,915
Total operating expenses
68,518 76,780 75,915 65,971
Operating loss
-47,519 -33,172 -43,183 -13,178
Interest income
6,538 7,248 7,538 -
Interest expense
7,665 8,243 8,665 9,168
Gain (loss) on marketable equity securities, net
44,201 4,967 941 -30,974
Interest income
---7,983
Asset impairment charges
1,565 1,858 4,865 -
Other, net
-17 -17 -31 32
Impairment on equity securities
---0
Total other income (expense)
41,492 2,097 -5,082 -31,405
Loss before income tax expense and noncontrolling interest
-6,027 -31,075 -48,265 -58,731
Income tax expense
0 -250 367 13,339
Net loss including noncontrolling interest
-6,027 -30,825 -48,632 -46,200
Net loss attributable to noncontrolling interest
0 0 -214 -647
Net loss attributable to xencor, inc
-6,027 -30,825 -48,418 -45,553
Net loss per share attributable to xencor, inc. - basic (in dollars per share)
-0.08 -0.41 -0.66 -0.57
Net loss per share attributable to xencor, inc. - diluted (in dollars per share)
-0.08 -0.41 -0.66 -0.57
Weighted-average shares used in calculating net loss per share - basic (in shares)
74,413,000 74,279,000 73,667,000 -121,870,050
Weighted-average shares used in calculating net loss per share - diluted (in shares)
74,413,000 74,279,000 73,667,000 -121,870,050
Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net lossattributable to xencor, inc-$6,027K Net loss includingnoncontrolling interest-$6,027K Gain (loss) onmarketable equity...$44,201K Interest income$6,538K Loss before incometax expense and...-$6,027K Total other income(expense)$41,492K Vir BiotechnologyInc.$1K Incyte Corporation$2,295K AlexionPharmaceuticals Inc$18,703K Other, net-$17K Asset impairmentcharges$1,565K Interest expense$7,665K Operating loss-$47,519K Collaborations, milestones, androyalties$20,999K Total operatingexpenses$68,518K General andadministrative$14,151K Research and development$54,367K

Xencor Inc (XNCR)

Xencor Inc (XNCR)